Medicine & Life Sciences
Actinobacteria
12%
Anti-Bacterial Agents
6%
Anti-Infective Agents
9%
Catheter-Related Infections
12%
Clinical Trials
6%
dalbavancin
81%
Diarrhea
7%
Enterococcus
11%
Fever
7%
Glycopeptides
36%
Half-Life
8%
Headache
8%
Infections
13%
Linezolid
12%
Lipoglycopeptides
82%
Pharmacokinetics
7%
Phase II Clinical Trials
11%
Phase III Clinical Trials
11%
Skin
15%
Soft Tissue Infections
11%
Staphylococcus
9%
Staphylococcus aureus
8%
Vancomycin
10%
Vancomycin-Resistant Enterococci
12%
Chemical Compounds
Antimicrobial Agent
33%
Dalbavancin
100%
Drug
5%
Glycopeptide
21%
Linezolid
14%
Pharmacokinetics
7%
Polypeptide Antibiotic Agent
10%
Reaction Half Life
9%
Resistance
18%
Semisynthetic Derivative
14%
Strain
6%
Vancomycin
12%